A Novel Monoclonal Antibody Targeting a Large Surface of the Receptor Binding Motif Shows Pan-neutralizing SARS-CoV-2 Activity Including BQ.1.1 Variant
L. de Campos-Mata, B. Trinite, A. Modrego, S. Tejedor Vaquero, E. Pradenas, N. Rodrigo Melero, D. Carlero, S. Marfil, A. Pons-Grifols, M. T. Bueno-Carrasco, C. Santiago, F. Tarres-Freixas, V. Urrea, N. Izquierdo, E. Riveira-Munoz, , G. Magri
This study characterizes a new monoclonal antibody, 17T2, that broadly neutralizes SARS-CoV-2 variants, including BQ.1.1, and shows in vivo prophylactic activity against Omicron BA.1.1.
bioRxiv · Jan 20, 2023 · PreprintImmunology